It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Post Surgery Pain Mangagement Drug Treatment Study

Clinical Trial Title: 
A phase 3, randomized, double-blind, placebo-controlled, multicenter, evaluation of the safety of N1539 following major surgery.
Clinical Trial Protocol ID: 
16021705
Clinical Trial Investigator Name: 
Adam C. Young, MD
Clinical Trial Protocol Description: 

The purpose of this study is to test a study drug for safety and pain management after an elective surgery.

Clinical Trial Eligibility Criteria: 

In order to participate you must be having surgery which would require a 48 hour hospitalization and not be pregnant or breastfeeding.

You will be excluded from the study if any of the following criteria apply to you:

  • Are HIV positive.
  • Have cancer.
  • Have a known bleeding disorder.
  • Have a history of alcohol abuse.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Pain Management
Contact Phone: 
(312) 942-2985
Contact Name: 
Sherry Robison